Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biontech Se ADR (BNTX)

Biontech Se ADR (BNTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,539,986
  • Shares Outstanding, K 226,262
  • Annual Sales, $ 121,620 K
  • Annual Income, $ -200,540 K
  • 60-Month Beta N/A
  • Price/Sales 163.18
  • Price/Cash Flow N/A
  • Price/Book 29.95
Trade BNTX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.46
  • Number of Estimates 4
  • High Estimate -0.36
  • Low Estimate -0.58
  • Prior Year -0.16
  • Growth Rate Est. (year over year) -187.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
58.81 +50.81%
on 09/24/20
97.29 -8.84%
on 10/19/20
+24.86 (+38.95%)
since 09/23/20
3-Month
54.10 +63.94%
on 09/04/20
97.29 -8.84%
on 10/19/20
+0.18 (+0.20%)
since 07/23/20
52-Week
16.12 +450.19%
on 11/01/19
105.00 -15.53%
on 03/18/20
+71.05 (+402.78%)
since 10/23/19

Most Recent Stories

More News
Pfizer (PFE) to Report Q3 Earnings: What's in the Cards?

Higher sales of Pfizer's (PFE) key brands, Eliquis, Ibrance and Inlyta, in the Biopharma segment are likely to have made up for lower sales in the Upjohn group in the third quarter.

PFE : 38.18 (+2.00%)
MRK : 79.83 (+0.78%)
GSK : 35.29 (+0.57%)
BNTX : 88.69 (+2.70%)
Retail and Core Retail Sales Jump in September

Retail and Core Retail Sales Jump in September.

PFE : 38.18 (+2.00%)
BNTX : 88.69 (+2.70%)
Retail Sales +1.9%, Industrial Production -0.6%

While September Retail Sales were ahead of expectations, Industrial Production last month was decidedly not.

PFE : 38.18 (+2.00%)
SPY : 345.78 (+0.34%)
QQQ : 284.74 (+0.20%)
DIA : 283.34 (-0.11%)
BNTX : 88.69 (+2.70%)
Moderna Gets Consent to File MAA for Coronavirus Vaccine in EU

Moderna (MRNA) gets permission from the European Medicines Agency to submit a marketing authorization application for mRNA-1273, its vaccine candidate against COVID-19.

AZN : 52.00 (+0.08%)
PFE : 38.18 (+2.00%)
MRNA : 70.53 (-0.44%)
BNTX : 88.69 (+2.70%)
BioNTech SE Sponsored ADR (BNTX) Gains But Lags Market: What You Should Know

BioNTech SE Sponsored ADR (BNTX) closed at $86.23 in the latest trading session, marking a +0.75% move from the prior day.

BNTX : 88.69 (+2.70%)
Biotech Stock Roundup: ALXN to Raise Guidance, BMY to Buy MYOK & Other Updates

The biotech sector remains in focus with regulatory, acquisition and other pipeline updates.

ALXN : 121.61 (+1.62%)
REGN : 579.81 (+0.71%)
GILD : 60.79 (+0.20%)
BMY : 60.13 (-1.04%)
MYOK : 222.97 (+0.37%)
CRVS : 3.96 (-1.00%)
BNTX : 88.69 (+2.70%)
Company News for Oct 7, 2020

Companies in the news are: KNSA, GMDA, BNTX, NAKD

NAKD : 0.0750 (-9.09%)
KNSA : 18.76 (+4.63%)
GMDA : 5.62 (-0.71%)
BNTX : 88.69 (+2.70%)
Pfizer, BioNTech Begin EU Rolling Filing of Coronavirus Vaccine

Pfizer (PFE) and partner BioNTech start rolling review of their coronavirus vaccine candidate, BNT162b2, in Europe.

JNJ : 145.24 (+0.11%)
AZN : 52.00 (+0.08%)
PFE : 38.18 (+2.00%)
BNTX : 88.69 (+2.70%)
Small-Caps, Energy Win the Trading Day

The Energy sector was one of the biggest winners on the day, coming after weeks of hard-hit commodity prices finally getting a little traction.

NVAX : 93.13 (-0.49%)
BNTX : 88.69 (+2.70%)
The Zacks Analyst Blog Highlights: MRNA, AZN, PFE and BNTX

The Zacks Analyst Blog Highlights: MRNA, AZN, PFE and BNTX

AZN : 52.00 (+0.08%)
PFE : 38.18 (+2.00%)
MRNA : 70.53 (-0.44%)
BNTX : 88.69 (+2.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany.

See More

Key Turning Points

2nd Resistance Point 91.51
1st Resistance Point 90.10
Last Price 88.69
1st Support Level 87.17
2nd Support Level 85.65

See More

52-Week High 105.00
Last Price 88.69
Fibonacci 61.8% 71.05
Fibonacci 50% 60.56
Fibonacci 38.2% 50.07
52-Week Low 16.12

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar